CBS News reports: The weight loss drug retatrutide has been touted as "Ozempic on steroids." It's still in clinical trials and not approved by the FDA, but a CBS News investigation found that hasn't stopped doctors from offering it, and it could come with serious side effects. Adam Yamaguchi reports.
national | health | CBS News | June 8, 2026 12:16 PM
Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
The weight loss drug retatrutide has been touted as "Ozempic on steroids." It's still in clinical trials and not approved by the FDA, but a CBS News investigation found that hasn't stopped doctors from offering it, and it could come with serious side effects. Adam Yamaguchi reports.
Source attribution
This PeeDeeWire article is based on reporting from CBS News and links readers to the original source for full context.
Read the original source report